MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
HTG Molecular Diagnostics Operating Cash Flow 2011-2026 | HTGM
Annual Operating Cash Flow HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.4 M | -16.5 M | -16.3 M | -16.7 M | -13.2 M | -16.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -13.2 M | -18.4 M | -16.3 M |
Quarterly Operating Cash Flow HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -16.4 M | -11.8 M | -5.94 M | - | -13.1 M | -8.9 M | -4.35 M | - | -12.7 M | -8.38 M | -3.93 M | - | -12.8 M | -8.77 M | -5.59 M | - | -10.6 M | -7.01 M | -2.7 M | - | -13.7 M | -9.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -2.7 M | -16.4 M | -9.2 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.48 B | $ 119.04 | 0.74 % | $ 36.2 B |  USA |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.83 | -4.39 % | $ 91.8 K | USA |
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 23.54 | -6.44 % | $ 247 M |  China |
 |
Celcuity
CELC
|
-83.5 M | $ 107.4 | -0.83 % | $ 4.24 B | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 27.57 | -1.5 % | $ 766 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 175.69 | -1.63 % | $ 8.71 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 13.79 | -2.89 % | $ 417 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-48.6 M | $ 15.5 | -1.59 % | $ 2.01 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.12 | -1.75 % | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 208.36 | -0.91 % | $ 23.1 B | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 204.01 | -0.91 % | $ 145 B | USA |
 |
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | $ 103.37 | 0.02 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
15.3 M | $ 8.74 | -0.34 % | $ 548 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.3 | -4.19 % | $ 292 M | Israel |
 |
DexCom
DXCM
|
1.44 B | $ 73.08 | -0.95 % | $ 28.5 B | USA |
 |
PerkinElmer
PKI
|
583 M | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
-1.48 M | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Quotient Limited
QTNT
|
-77.6 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 108.7 | 0.4 % | $ 8.97 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.18 B | $ 635.54 | -0.18 % | $ 51.1 B | USA |
 |
Illumina
ILMN
|
837 M | $ 129.56 | -2.51 % | $ 20.6 B | USA |
 |
Renalytix AI plc
RNLX
|
-30.1 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
VolitionRx Limited
VNRX
|
-25.9 M | $ 0.2 | -1.28 % | $ 19.2 M |  Singapore |
 |
CareDx, Inc
CDNA
|
42 M | $ 18.8 | 0.29 % | $ 1 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
-185 M | $ 93.3 | 1.16 % | $ 11.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 282.99 | -1.21 % | $ 23.5 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 78.84 | 3.33 % | $ 5.32 B | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 173.96 | -0.18 % | $ 29.9 B | USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 11.59 | -51.08 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
-22.1 M | - | - | $ 79.8 M | USA |
 |
Soleno Therapeutics
SLNO
|
46.8 M | $ 37.72 | -3.43 % | $ 1.92 B | USA |